A phase 1 study of weekly everolimus (RAD001) in combination with docetaxel in patients with metastatic breast cancer

Stacy Moulder*, Gregory Gladish, Joe Ensor, Ana Maria Gonzalez-Angulo, Massimo Cristofanilli, James L. Murray, Daniel Booser, Sharon H. Giordano, Abeena Brewster, Julia Moore, Edgardo Rivera, Gabriel N. Hortobagyi, Hai T. Tran

*Corresponding author for this work

Research output: Contribution to journalArticle

17 Scopus citations

Fingerprint Dive into the research topics of 'A phase 1 study of weekly everolimus (RAD001) in combination with docetaxel in patients with metastatic breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences